• FAIR
• IDMP
• AI COMMUNITY OF EXPERTS

13.30

 Registration and poster viewing 

15.00

Presidents Welcome - Becky Upton, President, Pistoia Alliance 

15.15

Keynote Presentation: 

Penn Medicine Cell and Gene Therapy From Innovation to Translation to Patients:
A Collaborative Academic to Industry Model

Professor Bruce Levine, Barbara and Edward Netter Professor in Cell Gene Therapy, University of Pennsylvania 

15.45

Keynote Presentation: 

Standard Delivery is Worth the Wait: How Standardized Study Data is SENDing Regulatory Toxicology into the 21st Century

Kevin Snyder, Associate Director, Non Clinical Informatics, FDA

16.15 

Elsevier Keynote Presentation: 

Harnessing Data and AI to Drive Innovation 

Mirit Eldor, Managing Director, Life Sciences Solutions, Elsevier

16.30

Advanced Insights using Real World Data

Jennifer van Camp, VP, R&D Data Analytics, AbbVie

16.45

Pistoia Alliance perspective and round up of the afternoon.

Christian Baber, Chief Portfolio Officer 

17.00 - 19.00

Close 

Welcome drinks reception and poster viewing, meet the Pistoia Alliance project managers 

November 13, 2024

08.30

Conference opens - interactive session 

08.30

Presidents Welcome - Becky Upton, President, Pistoia Alliance 

08.45

Keynote Presentation: Harnessing AI to Expedite R&D

John Chan, Head, ShinrAI Center for Artificial Intelligence and Machine Learning , Takeda

09.15

Pistoia Alliance AI perspective 

Vladimir Makarov, Project Manager, Pistoia Alliance 

09.30

Pistoia Alliance portfolio and new ideas session 

Christian Baber, Chief Portfolio Officer 

Thierry Escudier, Portfolio Lead

09.55

A Collaborative Approach to FAIR In Vitro Pharmacology Submission to Regulatory Agencies

Larry Callahan, FDA 

Chris Butler, Senior Principal Data Scientist, AbbVie 

10.10

Evolution and Evaluation of Scientific search and discovery 

Mark Sheehan, Vice President, Data Science Life Science Solutions, Elsevier 

10.25

Slowing down to speed up - unifying data and AI Governance 

Graeme King, Head of Data & AI Governance,  Amino Data 

10.40

Morning Coffee 

11.10

Leveraging Federated Learning to Enable Private Data Sharing in Pharma 

Dan Rozelle, VP of Data Analytics, Rancho BioSciences  

11.25

Enabling Science through High-Quality Data and Predictions

Jen Sexton, Director, CAS Custom Services

11.30 

Pistoia Alliance View Point on Data 

Giovanni Nisato, Project Manager, Pistoia Alliance 

12.00

ZS Associates white paper presentation 

Misaligned incentives in life sciences R&D: What’s holding us back from achieving data integration and better patient outcomes

Bruce Press, Principle ZS Associates

Adam Schneider, Director of Strategy & Operations 

12.25

 Lunch and Poster Viewing  

BREAKOUT SESSIONS 14.00 - 15.30

BREAKOUT ONE 

Semantic Management of Data 

A session focused on the importance of organization and governance of data & metadata to future-proof our data and allow the impact of the FAIR principles to be recognized.

14.00 Introduction to the session 

14.15 An open science approach to real world data standardization and real world evidence generation: lessons from OHDSI Patrick Ryan, Vice President, Observational Health Data Analytics, J&J Innovative Medicines & OHDSI 

14.35 Business Value Drivers of FAIR 
Genta Spahiu, Data Governance Lead, Pfizer 

14:50 Connect FAIR maturity matrix to business value 
John Apathy, Chief Solutions Officer, Life Sciences Industry Lead, XponentL

15.05 Panel discussion 

15.30 Close 

BREAKOUT TWO 

Applications of Data 

Data is an asset that only has value when used. This session focuses on the application of data to drive decisions whether through simple analytics or more complex approaches such as AI/ML

14.00 Introduction to the session 

14.15 Application of AI in drug discovery

Abhishek Pandey, Group Lead, Pharma Discovery, AbbVie 

14:30 Applications of AI in Clinical Development

Prateek Kacker, Director - Data Science and AI, Novartis

14.45 Revolutionizing Healthcare and Life Sciences with Data Models, AI Agents, and GenAI-Driven Insights, Sanjay Padhi,CTO, Tag.bio

15.00 Augmented Intelligence - keeping human in the loop of AI in GxP, Loganathan Kumarasamy, Director, Zifo 

15.15 Panel discussion

15.30 Close 

BREAKOUT THREE 

Sustainability Driven R&D

A session focuses on the sustainability best practices across the R&D value chain, from new approaches in toxicology to evaluating impact of clinical trials design on carbon footprint. 

 14.00 Introduction to the session 

14.15 How non animal models can contribute to your R&D sustainability objectives 

Alastair King, Head of Biology, Eurofins

14:30 How GSK is driving sustainability in R&D Steve Vitale, Green Lab Program Manager, GSK 

14.45 How to assess the carbon footprint of your clinical trials: outcome of Pistoia Alliance project 

15.00 Panel discussion 

15.30 Close 

15.30

Afternoon Coffee 

16.00

CSCS Community’s response to DEA’s Proposed Disposal Regulations and its Impact on Industry

Jessie Bin Song, Merck

16.30

Closing Keynote Address

Science Philanthropy Spotlight on AI and Patient-Driven Research

• Overview of the Chan Zuckerberg Initiatives science philanthropy model 
  
• Successes and challenges of patient-driven research in rare disease
• Future of AI and biology 
  

Genevieve Haliburton, Computational Biology Lead, Chan Zuckerberg Initiative 

Jeanie Kim, Program Manager, Chan Zuckerberg Initiative 

17.00

19.00 
Close 

Closing Remarks and networking